BioCentury | Mar 4, 2013
Company News

Organovo Holdings, Zen-Bio Inc. deal

...The companies partnered to produce 3D human tissue models for drug discovery and advanced tissue therapies. Zen-Bio...
BioCentury | Oct 17, 2011
Company News

Cyntellect, GT Life Sciences Inc., Intrexon deal

...purification, to identify genetically modified mammalian cell lines that secrete desirable therapeutic proteins, and maintain advanced tissue...
BioCentury | May 16, 2011
Finance

Healing Biotech IPOS?

...had $44 million in revenue and $8 million in operating income. Dermagraft was developed by Advanced Tissue Sciences Inc....
...& Nephew plc (LSE:SN; NYSE:SNN). S&N acquired Dermagraft and other assets for $7 million when Advanced Tissue...
BioCentury | Feb 28, 2011
Finance

Dermagraft redux

...credit. Advanced Tissue Sciences Inc. and partner Smith & Nephew plc (LSE:SN; NYSE:SNN) developed Dermagraft and TransCyte. When Advanced Tissue...
BioCentury | May 5, 2008
Emerging Company Profile

Histogen: Regenerating tissue science

...initial close of its series A round at $5.4 million. Histogen CEO Gail Naughton cofounded Advanced Tissue Sciences Inc....
...clinical phase," VP of R&D Robert Kellar told BioCentury. Kellar was project manager-lead scientist at Advanced Tissue...
BioCentury | May 24, 2004
Company News

Iken Tissue Therapeutics Inc. deal

...entered into an agreement to acquire Anginera from the trustee of the liquidating trust of Advanced Tissue...
BioCentury | Mar 17, 2003
Clinical News

CosmoDerm human-based collagen product regulatory update

...dermal filler for wrinkles. ATIS said the approval triggers a $2 million payment from IMDC. Advanced Tissue Sciences Inc....
BioCentury | Dec 9, 2002
Company News

Advanced Tissue, Smith & Nephew deal

...filed for reorganization under Chapter 11 of the U.S. Bankruptcy Code (see BioCentury, Oct. 14). Advanced Tissue Sciences Inc....
BioCentury | Nov 25, 2002
Finance

Restructuring watch

...Restructuring watch Date Company Staff cuts Notes Cash Years cash pre-cut Cash reporting date 11/13 Advanced Tissue...
BioCentury | Nov 4, 2002
Finance

Restructuring watch

...and hopes to end 2003 with three years of operating cash $464.0 3.6 9/30 10/10 Advanced Tissue...
Items per page:
1 - 10 of 197
BioCentury | Mar 4, 2013
Company News

Organovo Holdings, Zen-Bio Inc. deal

...The companies partnered to produce 3D human tissue models for drug discovery and advanced tissue therapies. Zen-Bio...
BioCentury | Oct 17, 2011
Company News

Cyntellect, GT Life Sciences Inc., Intrexon deal

...purification, to identify genetically modified mammalian cell lines that secrete desirable therapeutic proteins, and maintain advanced tissue...
BioCentury | May 16, 2011
Finance

Healing Biotech IPOS?

...had $44 million in revenue and $8 million in operating income. Dermagraft was developed by Advanced Tissue Sciences Inc....
...& Nephew plc (LSE:SN; NYSE:SNN). S&N acquired Dermagraft and other assets for $7 million when Advanced Tissue...
BioCentury | Feb 28, 2011
Finance

Dermagraft redux

...credit. Advanced Tissue Sciences Inc. and partner Smith & Nephew plc (LSE:SN; NYSE:SNN) developed Dermagraft and TransCyte. When Advanced Tissue...
BioCentury | May 5, 2008
Emerging Company Profile

Histogen: Regenerating tissue science

...initial close of its series A round at $5.4 million. Histogen CEO Gail Naughton cofounded Advanced Tissue Sciences Inc....
...clinical phase," VP of R&D Robert Kellar told BioCentury. Kellar was project manager-lead scientist at Advanced Tissue...
BioCentury | May 24, 2004
Company News

Iken Tissue Therapeutics Inc. deal

...entered into an agreement to acquire Anginera from the trustee of the liquidating trust of Advanced Tissue...
BioCentury | Mar 17, 2003
Clinical News

CosmoDerm human-based collagen product regulatory update

...dermal filler for wrinkles. ATIS said the approval triggers a $2 million payment from IMDC. Advanced Tissue Sciences Inc....
BioCentury | Dec 9, 2002
Company News

Advanced Tissue, Smith & Nephew deal

...filed for reorganization under Chapter 11 of the U.S. Bankruptcy Code (see BioCentury, Oct. 14). Advanced Tissue Sciences Inc....
BioCentury | Nov 25, 2002
Finance

Restructuring watch

...Restructuring watch Date Company Staff cuts Notes Cash Years cash pre-cut Cash reporting date 11/13 Advanced Tissue...
BioCentury | Nov 4, 2002
Finance

Restructuring watch

...and hopes to end 2003 with three years of operating cash $464.0 3.6 9/30 10/10 Advanced Tissue...
Items per page:
1 - 10 of 197